drugset / Trial / NCT05428215

Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

NCT05428215

Phase 4 Terminated 2 enrolled MaineHealth
RandomizedCrossoverTriple-blindTreatment

Summary

This crossover study will investigate the pharmacokinetics of oral versus sublingual administration of 17-beta-estradiol in the trans-female population.

Timeline

Start
2022-12-29
Primary completion
2023-07-20
Completion
2023-07-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator 17-beta estradiol Unknown Other